Search Results - "Wodaje, T"

High plasma lipoprotein(A) levels are associated with increased prevalence of cardiovascular disease and poorer metabolic control in patients with type 1 diabetes mellitus by Littmann, K., Wodaje, T., Alvarsson, M., Bottai, M., Eriksson, M., Parini, P., Brinck, J.

Get full text

The red blood cell as a mediator of endothelial dysfunction in patients with familial hypercholesterolemia and dyslipidemia by Mahdi, Ali, Wodaje, Tigist, Kövamees, Oskar, Tengbom, John, Zhao, Allan, Jiao, Tong, Henricsson, Marcus, Yang, Jiangning, Zhou, Zhichao, Nieminen, Anni I., Levin, Malin, Collado, Aida, Brinck, Jonas, Pernow, John

“…Background Patients with familial hypercholesterolemia (FH) display high levels of low‐density lipoprotein cholesterol (LDL‐c), endothelial dysfunction, and…”
Get full text

Remote ischemic conditioning fails to protect against ischemia-reperfusion injury in patients with untreated familial hypercholesterolemia by Kovamees, O, Mahdi, A, Wodaje, T, Verouhis, D, Brinck, J, Pernow, J

“…Abstract Background/Introduction Remote ischemic conditioning (RIC) is the action of brief periods of ischemia to a remote tissue and has been suggested to…”
Get full text

The Association of Lipoprotein(a) Plasma Levels With Prevalence of Cardiovascular Disease and Metabolic Control Status in Patients With Type 1 Diabetes by Littmann, Karin, Wodaje, Tigist, Alvarsson, Michael, Bottai, Matteo, Eriksson, Mats, Parini, Paolo, Brinck, Jonas

“…To investigate the association of the cardiovascular risk factor lipoprotein (Lp)(a) and vascular complications in patients with type 1 diabetes. Patients with…”
Get full text

P655High lipoprotein(a) plasma levels is associated with higher prevalence of cardiovascular disease and poor metabolic control in patients with type 1 diabetes by Littmann, K, Wodaje, T, Alvarsson, M, Bottai, M, Parini, P, Eriksson, M, Brinck, J

“…Abstract Background Lipoprotein(a) [Lp(a)] is a cardiovascular risk factor that has been shown to correlate to cardiovascular disease and aortic valve disease…”
Get full text

Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemia by Wodaje, Tigist, Mahdi, Ali, Venkateshvaran, Ashwin, Häbel, Henrike, Zenlander, Robin, Gaylard, Benjamin, Angelin, Bo, Pernow, John, Brinck, Jonas

“…Microvascular dysfunction underlies many cardiovascular disease conditions; little is known regarding its presence in individuals with high levels of…”
Get full text

Erythrocytes induce vascular dysfunction in COVID-19 by Mahdi, A, Collado, A, Tengbom, J, Jiao, T, Wodaje, T, Yang, J, Lundberg, J O, Zhou, Z, Pernow, J

“…Abstract Background Vascular injury has been implicated as a major cause of clinical complications in patients with coronavirus disease 2019 (COVID-19)…”
Get full text

Plasma Lipoprotein(a) measured in routine clinical care and the association with incident calcified aortic valve stenosis during a 14-year observational period by Wodaje, Tigist, Littmann, Karin, Häbel, Henrike, Bottai, Matteo, Bäck, Magnus, Parini, Paolo, Brinck, Jonas

“…Lipoprotein(a) [Lp(a)] is a causal cardiovascular risk factor recommended to be measured at least once in a lifetime. We aimed to establish the association…”
Get full text

The protective effect of remote ischemic conditioning is lost in patients with hypercholesterolemia by Kövamees, Oskar, Mahdi, Ali, Wodaje, Tigist, Verouhis, Dinos, Brinck, Jonas, Pernow, John

“…Remote ischemic conditioning (RIC), brief repetitive cycles of ischemia and reperfusion in remote tissues, is known to induce robust protection against…”
Get more information

Myocardial microvascular dysfunction in asymptomatic patients with hereditary dyslipidemia by Wodaje, T, Venkateshvaran, A V, Mahdi, A M, Zenlander, R Z, Angelin, B A, Pernow, J P, Brinck, J B

“…Abstract Introduction Microvascular dysfunction underlies the pathophysiology of many cardiovascular disease (CVD) conditions and is strongly associated with…”
Get full text

High-Density Lipoprotein function is modulated by the SARS-CoV-2 spike protein in a lipid-type dependent manner by Correa, Yubexi, Del Giudice, Rita, Waldie, Sarah, Thépaut, Michel, Micciula, Samantha, Gerelli, Yuri, Moulin, Martine, Delaunay, Clara, Fieschi, Franck, Pichler, Harald, Haertlein, Michael, Forsyth, V. Trevor, Le Brun, Anton, Moir, Michael, Russell, Robert A., Darwish, Tamim, Brinck, Jonas, Wodaje, Tigist, Jansen, Martin, Martín, César, Roosen - Runge, Felix, Cárdenas, Marité

“…[Display omitted] There is a close relationship between the SARS-CoV-2 virus and lipoproteins, in particular high-density lipoprotein (HDL). The severity of…”
Get full text

Erythrocytes Induce Vascular Dysfunction in COVID-19 by Mahdi, Ali, Collado, Aida, Tengbom, John, Jiao, Tong, Wodaje, Tigist, Johansson, Niclas, Farnebo, Filip, Färnert, Anna, Yang, Jiangning, Lundberg, Jon O., Zhou, Zhichao, Pernow, John

“…[Display omitted] •Patients hospitalized for COVID-19 display marked impairment in endothelial function, which is persistent following recovery from the acute…”
Get full text

High lipoprotein(a) plasma levels is associated with higher prevalence of cardiovascular disease and poor metabolic control in patients with type 1 diabetes by Littmann, K, Wodaje, T, Alvarsson, M, Bottai, M, Parini, P, Eriksson, M, Brinck, J

Get full text